OR WAIT 15 SECS
The Society for Clinical Research Sites has launched its newest initiative, the Site Advocacy Group, with TransCelerate BioPharma as its SAG partner.
The SAG initiative consists of SCRS members representing a broad spectrum of site professionals and clinical research sites who will partner with TransCelerate workstream members to exchange practical feedback on various topics. In return, industry leaders will share with the sites their key priorities and initiatives to elevate the ecosystem. It is hoped that the knowledge gained will help to promote site sustainability, enhance clinical research effectiveness and more closely align the work of the sites and industry across the research ecosystem.
Read the full release here.